Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Zimmer Biomet Holdings    ZBH

ZIMMER BIOMET HOLDINGS (ZBH)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
02/15/2018 02/16/2018 02/20/2018 02/21/2018 02/22/2018 Date
119.79(c) 120.48(c) 118.72(c) 118.68(c) 117.89 Last
1 266 113 696 599 663 733 988 644 467 342 Volume
+1.78% +0.58% -1.46% -0.03% -0.67% Change
More quotes
Financials ($)
Sales 2018 7 959 M
EBIT 2018 2 322 M
Net income 2018 1 080 M
Debt 2018 7 962 M
Yield 2018 0,85%
Sales 2019 8 159 M
EBIT 2019 2 444 M
Net income 2019 1 372 M
Debt 2019 6 711 M
Yield 2019 0,93%
P/E ratio 2018 25,13
P/E ratio 2019 20,69
EV / Sales2018 4,02x
EV / Sales2019 3,77x
Capitalization 24 030 M
More Financials
Company
Zimmer Biomet Holdings, Inc. designs, manufactures and markets orthopaedic reconstructive products, sports medicine, extremities and trauma products; craniomaxillofacial and thoracic products; dental implants; and related surgical products.The company operates through three geographical segments:... 
More about the company
Surperformance© ratings of Zimmer Biomet Holdings
Trading Rating : Investor Rating :
More Ratings
Latest news on ZIMMER BIOMET HOLDINGS
02/20ZIMMER BIOMET : Sponsors Bike Share Program for Warsaw Community
PU
02/15ZIMMER BIOMET : Rapid Recovery Program Marks Two Decades of Success in Europe
AQ
02/14INSIDER TRADING ACTIVITY ZIMMER BIOM : ZBH) – VP Sold 20,826 shares of Sto..
AQ
02/14MEDICAL SPLINT MARKET ANALYSIS, SEGM : Medical Splint Market Overview & Industry..
AQ
02/12ZIMMER BIOMET : Rapid Recovery Program Marks Two Decades of Success in Europe
AQ
02/08ZIMMER BIOMET : Rapid Recovery Program Marks Two Decades of Success in Europe
PR
02/01ZIMMER BIOMET : Comprehensive Shoulder System Database Retrieval
AQ
02/01ZIMMER BIOMET : Announces Fourth Quarter and Full-Year 2017 Results
AQ
02/01SPINAL FUSION SYSTEMS MARKET ANALYSI : Spinal Fusion Systems Market Overview & I..
AQ
01/30ZIMMER BIOMET (NYSE : ZBH) reported earnings of $2.10 per share meeting Walls St..
AQ
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
02/21OMAR ISHRAK : Pay if It Works -- WSJ
DJ
02/20MEDTRONIC : U.S. Revenue Drops -- Earnings Review
DJ
02/20MEDTRONIC MOVES TO A NEW HEALTH-CARE : Pay Only if It Works
DJ
02/15STRYKER : U.S. Regulators Extend Window for Critical Stroke Treatment
DJ
02/15STRAUMANN : margin outlook takes shine off revenue surge
RE
More sector news : Medical Equipment, Supplies & Distribution - NEC
Latest Tweets
02/21Zimmer Biomet Holdings Inc $ZBH Shares Bought by OppenheimerFunds Inc.  
02/21$ZBH - Somewhat Favorable Press Coverage Somewhat Unlikely to Affect Zimmer B.. 
02/20$ZMH Zimmer Biomet Holdings, Inc. email alerting service From our Stock News .. 
02/20Birch Hill Investment Advisors LLC Has $35.82 Million Holdings in Zimmer Biom.. 
02/19Clifford Swan Investment Counsel LLC Purchases 3,240 Shares of Zimmer Biomet .. 
More tweets
Qtime:76
News from SeekingAlpha
02/05PRECISION THERAPEUTICS : An Unloved Medical Device Company With Significant Upsi.. 
01/31Stryker Producing Excellent Results, But Expectations Are High 
01/31Premarket analyst action - healthcare 
01/30Zimmer Biomet's (ZBH) CEO Bryan Hanson on Q4 2017 Results - Earnings Call Tra.. 
01/30Zimmer Biomet Q4 revenues up 3%; non-GAAP EPS down 2%; updates guidance 
Chart ZIMMER BIOMET HOLDINGS
Duration : Period :
Zimmer Biomet Holdings Technical Analysis Chart | ZBH | US98956P1021 | 4-Traders
Technical analysis trends ZIMMER BIOMET HOLDINGS
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 141 $
Spread / Average Target 19%
EPS Revisions
Managers
NameTitle
Bryan C. Hanson President, Chief Executive Officer & Director
Larry C. Glasscock Non-Executive Chairman
Adrian Furey Senior VP-Global Operations & Logistics
Daniel P. Florin Chief Financial Officer & Director
David J. Kunz VP-Global Quality, Clinical & Regulatory Affairs
Sector and Competitors
1st jan.Capitalization (M$)
ZIMMER BIOMET HOLDINGS-1.62%24 030
MEDTRONIC PLC1.07%109 254
BAXTER INTERNATIONAL3.71%36 531
ALIGN TECHNOLOGY14.97%20 216
HOYA CORPORATION-3.59%19 635
TERUMO CORP2.60%19 495